The higher the bleeding risk, the greater the benefit of radial access in terms of mortality

Original title: Baseline bleeding risk and arterial access site practice in relation to procedural outcomes after percutaneous coronary intervention. Presenter: Mamas A. Mamas et al. J Am Coll Cardiol. 2014;64:1554-1564.

The transradial approach has been associated with reduced access site related bleeding complications as well as a reduced mortality in the context of PCI. It seems reasonable to assume that baseline bleeding risk could also influence the benefit associated to the transradial approach, but it has not yet been established.

This trial studied the relationship between baseline bleeding risk, the transradial approach and post PCI events of all patients included in the British Cardiovascular Intervention Society database.

Baseline bleeding risk was calculated with the modified Mehran score in 348689 patients undergoing PCI between the years2006 and 2011. Patients were divided according to score in 4 categories of risk (low <10, moderate 10-14, high 15-19 and very high ≥20). The impact of baseline risk was analyzed on mortality at 30 days, according to access site.

Radial access was associated to a reduction of 35% mortality at 30 days (OR 0.65, IC 95% 0.59 to 0.72; p < 0.0001) and this reduction was associated to baseline bleeding risk (for those with

Conclusion

The transradial approach was independently associated to a reduction of mortality at 30 days and the magnitude of this effect was associated to bleeding risk. PCI patients with higher risk of bleeding are the ones that most benefit from the transradial approach.

Editorial Comment

In this study of the daily practice it was observed that 43% of patients with the lowest bleeding risk received the radial approach and, unexpectedly, only 40% of patients with the highest bleeding risk saw the same benefit. Even though there is enough evidence to adopt the transradial approach in all patients, we should give special attention to those with higher risk of bleeding, risk that should be calculated prior to intervention and should be known by the operator for him to make an informed decision on the most appropriate access site.

SOLACI

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....